Macrophilone A 5 is a pyrroloiminoquinone from the stinging hydroid Macrorhynchia philippina. 4 The structure of macrophilone A 5 was predicted using long-range NMR correlations and DFT calculations and confirmed by synthesis.
Terrazoanthine A 6, from the zoantharian Terrazoanthus onoi, is a representative of a new structural class of 2-aminoimidazole alkaloids. 5 A biosynthetic pathway to terrazoanthine A 6, involving a [4+2] cycloaddition, has been proposed. Meyeniin A 7, from tubers of Lepidium meyenii (maca), is a novel sulfur-containing hexahydroimidazo [1,5-c ]thiazole derivative. 6 The structure of meyeniin A 7 was confirmed by X-ray analysis and biomimetic synthesis. Macahydantoin A 8, a thiohydantoin derivative with a new skeleton, was also isolated from Lepidium meyenii. 7 The structure of macahydantoin A 8 was confirmed by synthesis. The Cterminus peptide modification found in leupeptazin 9, a metabolite of a Streptomyces sp., has not been found in nature before. 8 Leupeptazin 9 shows moderate inhibitory activity towards the collagenase cathepsin Κ.
A sponge symbiotic association of Plakortis halichondrioides and Xestospongia deweerdtae is the source of an inseparable mixture of plakortinic acids A 10 and B 11
that have an unusual bicyclo[4.2.0]octane unit. 9 It is proposed that this ring system is formed from a linear tetraene precursor. The mixture of plakortinic acids A 10 and B
11
shows cytotoxic activity at submicromolar concentration. is the first spirostanol to be found in animals. Streptomyces spheroids has identified the active site residues responsible for binding the substrate. 21 One of these residues, His120 was also shown to deprotonate the phenolic 7-hydroxyl, locking the substrate in position for the subsequent methyl transfer step. The products of a putative 2-hydroxyphenylthiazoline biosynthetic gene cluster from the genome of Streptomyces venezuelae ATCC 10712 include the known 2-hydroxyphenylthiazolines thiazostatin 26 and watasemycin 27. 22 Gene deletion experiments identified a type B radical-SAM methylase homologue that methylates the thiazoline ring of thiazostatin during the final biosynthetic step to form watasemycin.
The last two steps of the biosynthesis of the broad-spectrum natural product antibiotic fosfomycin 28 have been characterised using a combination of in vitro activity reconstitution and crystallographic analysis of the enzymes involved. 23 The reductase Psf3 was shown to convert 2-oxopropylphosphonate to (S)-2-hydroxypropylphosphonate, which is then converted to fosfomycin by a Psf4-catalysed epoxidation. A genome-mining approach has led to a comprehensive understanding of the biosynthesis of lipopeptides in myxobacteria. 24 Identification of potential producer strains allowed the discovery and isolation of four novel lipopeptide core types (e.g. 29).
The biocatalytic total synthesis of the bacterial polycyclic tetramate ikarugamycin 30, a compound which shows anti-leukemic and anti-inflammatory activity has been achieved using three recombinant enzymes, IkaABC. 25 The one-pot, three-enzyme The first example of a biocatalytic N-formylation of amines has been reported. 27 The process which uses Novozyme 435 (lipase B from Candida antarctica) and ethyl formate was shown to be general and scalable for a wide range of aliphatic and aryl amines (Scheme 2). A one-pot two-step conversion of amines to oximes has been developed using a lipase mediated perhydrolysis of ethyl acetate to generate a peracid, which then performs an oxidation to give the oxime (Scheme 3). 28 The optimal method utilised lipase B from Candida antarctica and gave the majority of products in excellent yields by a simple extraction protocol. An optimised, multi-gram scale chemoenzymatic synthesis of L-threo-3-benzyloxyaspartate 31 has been reported using methylaspartate ammonia lyase (MAL-384A). 29 Modifications such as the use of ammonia and high pH led to >98% conversion and 80% isolated yield of 31 (Scheme 4), which is used as a building block for the preparation of probes to study excitatory amino acid transporters. The cloning and overexpression of hydroxynitrile lyases from Prunus communis has led to the identification of PcHNL5 as an excellent biocatalyst for asymmetric hydrocyanation. 30 The enzyme was found to convert a range of aromatic aldehydes to valuable chiral cyanohydrin building blocks in excellent yields and optical purities (Scheme 5).
A one-pot two-step asymmetric synthesis of 2-substituted succinate derivatives has been developed using a rhodium-catalysed diazocoupling, followed by an enereductase mediated reduction of the resulting E-alkene. 31 Screening a range of ene- 
